venBio Select Advisor »

Avalo Therapeutics Ord shares owned by venBio Select Advisor

Quarter-by-quarter ownership of Avalo Therapeutics Ord (AVTX) shares owned by venBio Select Advisor from 13F filings

Historical chart of venBio Select Advisor investment in Avalo Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Avalo Therapeutics Ord held by venBio Select Advisor consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avalo Therapeutics Ord by venBio Select Advisor

Quarter filed Position value Share count Share price at filing
2026-03-31 $21M 1.4M 14.93

More positions owned by venBio Select Advisor

United Therapeutics Corp Common (UTHR)
Ascendis Pharma Sponsored ADR (ASND)
Madrigal Pharmaceuticals Common (MDGL)
Krystal Biotech Common (KRYS)
Argenx Se Sponsored ADR (ARGX)
Arrowhead Pharmaceuticals Common (ARWR)
Kymera Therapeutics Common (KYMR)
Apellis Pharmaceuticals Common (APLS)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Xenon Pharmaceuticals Common (XENE)
Structure Therapeutics Sponsored Ads (GPCR)
Terns Pharmaceuticals Common (TERN)
Vera Therapeutics Common (VERA)
Revolution Medicines Common (RVMD)
Cytokinetics Common (CYTK)

View all positions for venBio Select Advisor

Top funds holding Avalo Therapeutics Ord

FMR
BVF
venBio Select Advisor
Affinity Asset Advisors
Logos Global Management
Nantahala Capital Management
UBS Group
Caption Management
Point72 Asset Management
Farallon Capital Management
Caligan Partners
Rtw Investments
Adage Capital Partners GP
Millennium Management
Vanguard Group

View all funds holding Avalo Therapeutics Ord